SEC Investigating Cassava Sciences, Developer of Experimental Alzheimer’s Drug

  • 📰 WSJ
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

United States Headlines News

United States Latest News,United States Headlines

The SEC is investigating claims that Cassava Sciences, the sixth-best performing U.S. stock this year, manipulated research results of its experimental Alzheimer’s drug

Cassava Sciences, one of best-performing U.S. stocks this year, denies claims that it manipulated research results

Some images in journal articles about the efficacy of Cassava Sciences’ Alzheimer’s drug appeared to have been improperly altered, according to short sellers and some independent researchers.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Thanks.. but fk shorties investigation

hilarious reading your hit piece article. How do you not even talk about the 99% denial rate of citizen petitions or the fact that the fda knows most of them are filed by big competitors for nefarious purposes. How do you have 0 integrity as journalists

Why did you not include any mention that Bredt works at MPMCapital ? He was hired in April a few months before the CP. I think the SEC_Enforcement might be interested in this. It also appears they have tried scrubbing his name from their website…

The investigation is probably a due act given all the noise made around $SAVA stock, and not a conviction ! The article is a NO NEWS, only a good chronological summary of what's happening since the filing of the Petition. A part names of the 2 guys all the rest is well known !

More pressure on $SAVA

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Biogen shares slide 4% after EU advisory committee says it can't agree to endorse company's Alzheimer's disease drugBiogen Inc. shares undefined slid 4% in premarket trade Wednesday, after the company said it had received a 'negative trend vote' from an advisory committee... Biden even has a Alzheimer Disease drug? Cool
Source: MarketWatch - 🏆 3. / 97 Read more »

Pfizer seeks FDA emergency use authorization for its experimental Covid-19 antiviral pillPfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid. I would think that most people who will need this are unvaccinated so why would they trust a pill but not a vaccine from Pfizer? For how long should these Palestinians remain on hunger strike for the world and the international community to pay attention? These Palestinian detainees have been held in the Israeli prisons without any charge or trial, and they're only demanding their freedom! FreeThemAll People can know every fact about Covid but invite the information for what the government is pushing. . fact. Unvaccinated people are no more a threat than vaccinated. Fact if you are going to get Covid you'll get it whether you're vaccinated or not
Source: cnnbrk - 🏆 393. / 55 Read more »

Column: How the FDA's lousy judgment and a greedy drug company combined to hit Medicare members hardThe FDA approved an unproven Alzheimer's drug, and its manufacturer priced it in the stratosphere. Result: Medicare members get higher premiums. good luck
Source: latimes - 🏆 11. / 82 Read more »

Pfizer asks FDA to authorize Covid antiviral pillsPfizer asked the FDA to authorize its oral Covid antiviral pill called Paxlovid. The treatment is highly effective in reducing the risk of hospitalization. 'That' will help people that are afraid of Needles? fakenews: CNN, BBC, WP, AFP
Source: NBCNews - 🏆 10. / 86 Read more »

Pfizer Seeks FDA Emergency Use Authorization for Its COVID-19 PillPfizer has signed a deal to allow other manufacturers to make its experimental COVID-19 pill, possibly opening up access to treatment to countries across the world: This is a good move For unfortunately the world getting frustrating because of the pandemic which everybody known that it engineered through the Chinese laboratory 🧪
Source: WebMD - 🏆 709. / 51 Read more »

Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pillPfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. Gosh they are making so much money.... That's the general idea isn't it? You can keep your nauseating pill Wish those on here having a go would actually read it first rather than making themselves look daft Test on the poor ...hah
Source: CNN - 🏆 4. / 95 Read more »